2026 NPPES data Cornea and External Diseases Specialist Physician NPI 1285138503 MD
Verify on CMS →

RAKHI MELVANI, MD

Cornea and External Diseases Specialist Physician in IRVINE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
726
Medicare Part D claims · 251 beneficiaries · Cornea and External Diseases Specialist Physician avg: 1K
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
87.3837/100
▲ 4 pts above national avg 83.1 · [object Object]
Industry payments
$3.8K
39 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: RAKHI MELVANI, MD is a Cornea and External Diseases Specialist Physician ([object Object]) practicing in IRVINE, California with a Medicare Part D prescribing footprint of 726 claims across 251 beneficiaries — 51% brand-name prescribing . Their CMS MIPS Final Score of 87.3837/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $3.8K across 39 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: RAKHI MELVANI, MD reported a CMS MIPS final score of 87.3837 out of 100, above the 83.1 national average, and filed 726 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

RAKHI MELVANI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

RAKHI MELVANI, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 03/21/2018

NPI 1285138503

Primary specialty

Cornea and External Diseases Specialist Physician

Rare

294 US NPIs in this specialty

Medicare Part D claims

726 41% vs specialty avg

2023 prescription claims

Specialty avg: 1,232

MIPS final score

87.3837/100 4.28370000000001% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in California

How Cornea and External Diseases Specialist Physician compares to other specialties among California providers

California providers

Cornea and External Diseases Specialist Physician share within California

1. Cornea and External Diseases Specialist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cornea and External Diseases Specialist Physician share within California

Medicare quality performance — MIPS

RAKHI MELVANI, MD's 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average

High performer (top quartile)
MIPS Final Score
87.3837/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cornea and External Diseases Specialist Physician) — 87.3837/100 vs national avg 83.1

0%100%National avg83%87.4%
MIPS final score (Cornea and External Diseases Specialist Physician) — 87.3837/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAKHI MELVANI, MD is a Cornea and External Diseases Specialist Physician provider practicing in IRVINE, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1285138503. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RAKHI MELVANI, MD appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider holding MD credentials at 850 HEALTH SCIENCES RD, IRVINE, CA, 92617, with a listed phone of (949) 824-2020. NPI 1285138503 was issued on 03/21/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MELVANI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 726 prescription claims written by this provider, covering 251 Medicare beneficiaries and totaling roughly $167K in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 87.3837/100 for the 2023 performance year (Quality 99.6023, Cost 58.476), compared with the national average of 83.1.

Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

850 HEALTH SCIENCES RD
IRVINE, CA 92617

Provider Details

NPI 1285138503
Specialty Cornea and External Diseases Specialist Physician
Credentials MD
Gender Female
NPI Issued 03/21/2018

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

87.3837
Final Score
Avg: 83.1
99.6023
Quality
58.476
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where RAKHI MELVANI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GORDON SCHANZLIN NEW VISION INSTITUTE, INC. A PROFESSIONAL MEDICAL COR
LA JOLLA, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RAKHI MELVANI, MD. Source: openpaymentsdata.cms.gov.

Total received

$3.8K

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RAKHI MELVANI, MD. To verify RAKHI MELVANI, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

RAKHI MELVANI, MD — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 726 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

726
Total Claims
$167K
Total Drug Cost
251
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
998
Total Day Supply
26,045
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$152K
Generic Drug Cost
$14K
Antibiotic Claims
23

Patient Demographics

Average Patient Age
76.1 years
Avg HCC Risk Score
1.43
Gender Split
59% female / 41% male
Age Distribution
<65: 14, 65-74: 90, 75-84: 104, 85+: 43

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisolone Acetate
121
Moxifloxacin
Moxifloxacin Hcl
100
Restasis
Cyclosporine
64
Xiidra
Lifitegrast
48
Erythromycin
Erythromycin Base
46
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
33
Cyclosporine
30
Latanoprost
27
Fluorometholone
24
Brimonidine Tartrate
20

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cornea and External Diseases Specialist Physician Overview

How RAKHI MELVANI, MD fits within the Cornea and External Diseases Specialist Physician landscape nationally.

294
Cornea and External Diseases Specialist Physician Providers in US
43
States with Cornea and External Diseases Specialist Physician
1,232
Avg Claims per Provider

RAKHI MELVANI, MD's 726 claims are below the specialty average of 1,232.

Nearby Cornea and External Diseases Specialist Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as MELVANI.

Compare Cornea and External Diseases Specialist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAKHI MELVANI, MD's specialty?
RAKHI MELVANI, MD specializes in Cornea and External Diseases Specialist Physician and practices in IRVINE, California. Credentials: MD.
How much does RAKHI MELVANI, MD prescribe under Medicare Part D?
In 2023, RAKHI MELVANI, MD wrote 726 Medicare Part D claims totaling $167K in drug costs for 251 beneficiaries.
What is RAKHI MELVANI, MD's Medicare quality score?
RAKHI MELVANI, MD has a CMS MIPS Final Score of 87.3837/100 (Quality: 99.6023, Cost: 58.476). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RAKHI MELVANI, MD located?
RAKHI MELVANI, MD is located at 850 HEALTH SCIENCES RD, IRVINE, CA, 92617. Phone: (949) 824-2020.
What is RAKHI MELVANI, MD's NPI number?
RAKHI MELVANI, MD's National Provider Identifier (NPI) is 1285138503, issued on 03/21/2018.
Does RAKHI MELVANI, MD prescribe more brand-name or generic drugs?
RAKHI MELVANI, MD's prescribing is 51% brand-name and 49% generic drugs by claim count, with $152K in brand drug costs.
How many Cornea and External Diseases Specialist Physician providers are there in the US?
There are 294 Cornea and External Diseases Specialist Physician providers across 43 states in the US. The average Cornea and External Diseases Specialist Physician provider writes 1,232 Medicare Part D claims per year.
What drugs does RAKHI MELVANI, MD prescribe most often?
Based on 2023 Medicare Part D data, RAKHI MELVANI, MD's most frequently prescribed drugs include Prednisolone Acetate, Moxifloxacin, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RAKHI MELVANI, MD accept Medicare?
RAKHI MELVANI, MD appears in CMS Medicare data with 726 Part D claims and 251 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAKHI MELVANI, MD's credentials?
RAKHI MELVANI, MD's NPI is 1285138503 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology